The poor prognosis of urothelial carcinoma relates to higher expression of Glucosidase II α-subunit (GANAB protein), which is a regulator of glycosylation that could be used as a prognostic biomarker for urothelial carcinoma. This evidence concerns the gene GANAB and urothelial carcinoma.